Summary:
A new PMJAY rule excluding fellowship-trained oncologists without recognized super-specialty degrees has raised concerns about limiting cancer care access in India. Over 300 experienced specialists may be affected, potentially worsening the shortage of oncology services. Medical experts and associations are urging authorities to revisit the criteria, emphasizing that fellowship programs have historically been a key route for oncology training.
A recent provision under the PMJAY scheme that disqualifies fellowship-trained oncologists lacking formally recognized super-specialty qualifications could restrict access to cancer treatment in India.
Under the updated Ayushman Bharat PMJAY guidelines, numerous highly experienced cancer specialists have been deemed ineligible to provide care, raising concern within the medical community. This decision stems from the requirement for NMC-recognized super-specialty degrees—such as DM, MCh, or DrNB—despite many practitioners possessing extensive fellowship training and significant clinical expertise.
Specialists caution that more than 300 oncologists nationwide may be impacted, which could further strain cancer care services in a country already dealing with a shortage of experts. They note that fellowship programs have traditionally been the main pathway for oncology training. Medical associations are now calling on authorities to reconsider the criteria to avoid disruptions in patient care.
Related posts:
FDA Approves First At-Home Cervical Cancer Screening Device: A Game Changer in Women’s Health
Shocking Shift 25% of Lung Cancer Patients Are Young Non-Smoking Women
Ovarian Cancer Warning Signs: Experts Reveal Symptoms Often Mistaken for Menstrual Pain
New Blood Test Detects Lung Cancer One Cell at a Time, Study Finds
India launches a funding initiative to support AI-driven cancer diagnostics
